Navigation Links
The Quantum Group Announces Strategic Technology Alliance
Date:2/26/2008

s allows us to deliver an effective springboard for providers to accomplish their ultimate goals of treating more patients, more effectively, at more efficient costs."

Noel J. Guillama, President & CEO of The Quantum Group added, "This alliance brings immediate and exponential value to the healthcare industry. It will empower our patients with information, enable our providers with higher efficiencies, set our payer partners apart through documentable quality of care and extend the science of healthcare through the tremendous knowledge base aggregated by this system. We are a Company driven by innovations and this partnership significantly contributes to the comprehensive platform we have outlined in our business model. Our Board of Directors approved the Company expenditure of $1 million this year to roll out this initiative. Our goal is to raise the bar industry-wide to achieve a new standard in the quality of patient care."

About The Quantum Group, Inc.

The Quantum Group is a Florida-based organization. The Company builds and manages healthcare systems and offers consulting and outsourcing services that will be leveraged by leading-edge technology to the nation's largest and fastest growing industry- healthcare.

The Company is engaged in the development and execution of a series of innovative patent-pending technology initiatives designed to make Quantum one of the state's leading providers of business solutions for the healthcare industry. Through its growing number of over 1,800 contracted physicians and managed care relationships in the state of Florida, the Company believes it is positioned to bring increased efficiencies to the Florida healthcare industry.

About Net.Orange, Inc.

Net.Orange(TM) simplifies an increasingly complex healthcare system through robust solutions that are designed to be visually-intuitive, rapidly deployed, and managed with ease. Net.Orange's innovative cOS(TM) (Clinical Operating System) solu
'/>"/>

SOURCE The Quantum Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. The Quantum Group to Present at the Jesup & Lamont Emerging Growth Stock Conference on February 28th
2. The Quantum Group Reports 4th Quarter and Year End Results for Fiscal Year 2007
3. The Quantum Group, Inc. Announces Separation of Units
4. Results promising for computational quantum chemical methods for drug development
5. The Quantum Group, Inc. Completes $13.2 Million Public Offering and Initiates Trading on the American Stock Exchange Under Symbol QGP
6. American Stock Exchange Lists the Common Stock and Units of The Quantum Group, Inc.
7. Quantum Foundation Makes a Half Million Dollars Available to Federally Qualified Health Centers
8. Quantum light beams good for fast technology
9. The Ensign Group Establishes $50 Million Credit Facility with GE Healthcare Financial Services
10. Vital Health Technologies, Inc. / Caribbean American Health Resorts Inc. Acquires Momentum Medical Group, Inc.
11. Justice Department Requires Divestiture in UnitedHealth Groups Acquisition of Sierra Health Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2008)...most from chemo after surgery, study says , ...f 15 genes may help determine which patients with ...ence a recurrence and, therefore, benefit the most...tension, the same genetic signature may also ident...cer who would be able to forego chemotherapy. ,...
(Date:5/16/2008)...e/ -- As tropical storms,continue to batter the af...yclone Nargis are vulnerable to diseases and other...ance, as exposure to the foul weather and,malnutri... "The people living in these conditions urgently ...et back on their feet," said David Meltzer,senior...
(Date:5/16/2008)... 2007, WASHINGTON, May 16 /PRNewswire-USNewswire/...eaths, the National Cancer Institute (NCI) investe...cancer research in 2007,according to updated stat..., The two other federal agencies with significant...ontrol and Prevention (CDC) and the,Department of ...
(Date:5/16/2008)... -- CryoCor, Inc. (Nasdaq:,CRYO), a medical device...thmias, announced today that on May 8, 2008, two a...plaint in the Superior Court of the State,of Calif...ach member of the,Board of Directors of CryoCor, C...laint is styled Secondido, et al. v. CryoCor, Inc....
Breaking Medicine News(10 mins):Health News:Gene Signature May Predict Recurrence of Lung Cancer 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 3Health News:Myanmar Cyclone Survivors Face New Challenges 2Health News:Lung Cancer Still Lowest in Federal Funding 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 3Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 4
...reatest challenges facing researchers today, and r...akthrough to contain a growing epidemic.// The Wor...e a billion people in the world tackling overweigh... are obese. Scientists have narrowed their sights...
...children in deep sleep awoke to recordings of thei...ering them out of their bedrooms –although they sl... Dr. Gary Smith, one of the co-authors of the stu...revious research which showed that what works for ...
...e to 100,000 people affected by chikungunya, a vir...ster V.S. Achuthanandan Tuesday blamed experts for...he disease. "Experts are confusing us because some...overnment is doing its best to contain it. We will...
...f coronary heart diseases, say experts."Coronary h...The use of mustard oil can reduce the risk of CHD,...ent of cardiothoracic diseases at New Delhi's All ...AIIMS). Mustard oil is one of the healthiest edib...
Other Medicine News:Health News:Brain behind the Brawn: Vital Molecule in the Brain Controls Appetite 2Health News:Mummy’s Voice More Effective than Smoke Alarm 2Health News:Mustard Oil can Reduce the Risk of Heart Diseases 2
(Date:5/15/2008)..., Switzerland, May 15 /- Patients wit...most common cancers, can expect,further treatment ...in(R),(trastuzumab) following new data that is bei...cal Oncology (ASCO) annual meeting in Chicago at,t...attend the meeting which,is the premier event for ...
(Date:5/15/2008)...I Data Presented at ASCO Showed Acceptable Tolerab...rade 3 and 4 Neuropathy, WOODCLIFF LAKE, N.J., Ma...apeutic agent eribulin mesylate (E7389) demonstrat...women with locally advanced or metastatic,breast c...e II clinical,trial. The study also suggests that ...
(Date:5/15/2008)...ssure reductions demonstrated in Blacks, Hispanics...d Obese Individuals, PARSIPPANY, N.J., May 15 /PR... that data presented at the American Society of,Hy...ng (ASH 2008) in New,Orleans demonstrated that the...d olmesartan medoxomil) safely and effectively hel...
(Date:5/15/2008)...ZELL, Switzerland, May 15 /- Ergonex ... and Drug Administration (FDA) has,granted orphan ... pulmonary,arterial hypertension (PAH). Terguride ...Phase II trial in Europe., "The FDA,s grant of or...ges and strengthens our development program by off...
Breaking Medicine Technology:New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 2New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 3New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 4New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 5New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 6Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2007 Financial Results 1582 1deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2007 Financial Results 1582 2Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals 697 1Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals 697 2Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals 697 3AIDS Stopped in Haiti Before U S 4956 1AIDS Stopped in Haiti Before U S 4956 2AIDS Stopped in Haiti Before U S 4956 3ShangPharma Receives Strategic Investment from TPG 1577 1ShangPharma Receives Strategic Investment from TPG 1577 2ShangPharma Receives Strategic Investment from TPG 1577 3ShangPharma Receives Strategic Investment from TPG 1577 4
..., July 9 /CNW/ - Insmed Inc. (NASDAQ:INSM), a ,bio...and approval,of drugs for the treatment of metabo...nced that it will present at this,week,s C.E. Unt...s Conference in New York City. , The conference...,York City, will run from Tuesday, July 10th thro...
...(BUSINESS WIRE)--Jul 9, 2007 - Neose Technologies,... present at the,C.E. Unterberg, Towbin Emerging Gr... Oriental Hotel in New York City from July,10-12, ...2:00 p.m.,(EDT) on Tuesday, July 10, 2007. The pre...eplay via the following link:, http://www.wsw.com/...
Other Medicine Technology:Insmed Inc. to Present at C.E. Unterberg, Towbin Growth Conference 2
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: